Synthesis and membrane action of polymyxin B analogues.
We have designed synthetic peptides that mimic the primary and secondary structure of the cationic lipopeptide antibiotic polymyxin B (PxB) in order to determine the structural requirements for membrane action and to assess possible therapeutic potential. Two analogues with related sequences to that of PxB, but including synthetic simplifications (disulphide bridge between two cysteines in positions 4 and 10, N-terminal nonanoic acid), have been synthesized. Peptide-lipid interactions have been studied by fluorescence resonance energy transfer between pyrene and 4,4-difluoro-5-methyl-4-bora-3alpha,4alpha-diaza-s-indacene-3-dodecanoyl (BODIPY)probes covalently linked to phospholipids, and the possibility of membrane disruption or permeabilization has been assessed by light scattering and fluorescence quenching assays. The synthetic peptide sP-B, which closely mimics the primary and secondary structures of PxB, binds to vesicles of anionic 1-palmitoyl-2-oleoylglycero-sn-3-phosphoglycerol (POPG) or of lipids extracted from Escherichia coli membranes, and induces apposition of the vesicles and selective lipid exchange without permeabilization of the membrane. We conclude that sP-B forms functional vesicle-vesicle contacts that are selective, as previously described for PxB. The second analogue, sP-C, has a permutation of two amino acids that breaks the hydrophobic patch formed by D-Phe and Leu residues on the cyclic part of the sequence. sP-C lipopeptide is more effective than sP-B in inducing lipid mixing, but shows no selectivity for the lipids that exchange through the vesicle-vesicle contacts, and at high concentrations has a membrane-permeabilizing effect. The deacylated and non-antibiotic derivative PxB-nonapeptide (PxB-NP) does not induce the formation of functional intervesicle contacts in the range of concentrations studied.
Clausell
Adrià
A
Physical Chemistry Department, Faculty of Pharmacy, University of Barcelona, Avn. Joan XXIII s/n, 08028 Barcelona, Spain.
Rabanal
Francesc
F
Garcia-Subirats
Maria
M
Asunción Alsina
M
M
Cajal
Yolanda
Y
D002462:Cell Membrane / Q000187:drug effects*; D002463:Cell Membrane Permeability; D004220:Disulfides; D004926:Escherichia coli / Q000648:ultrastructure; D031541:Fluorescence Resonance Energy Transfer; D008081:Liposomes; D010455:Peptides / Q000138:chemical synthesis / Q000494:pharmacology; D010715:Phosphatidylglycerols / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D011112:Polymyxin B / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology
D004220:Disulfides; D008081:Liposomes; D010455:Peptides; D010715:Phosphatidylglycerols; D010743:Phospholipids; C060037:1-palmitoyl-2-oleoylglycero-3-phosphoglycerol; D011112:Polymyxin B